Literature DB >> 2859278

Drugs and the quality of life: the patient's point of view.

R Diamond.   

Abstract

Although research has established the effectiveness of antipsychotic drugs in treating schizophrenic patients, the issue of the quality of life of patients on longterm medication has not been as clearly determined. The patient's and clinician's understanding of this criterion, both objective and subjective, is discussed. Social functioning, acceptance of dose, compliance or lack of compliance, and the relative benefits of medication are factors that contribute to treatment goals. Case examples are presented to demonstrate these variables and their impact on the outcome of treatment with antipsychotic medication and on the patient's quality of life.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2859278

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  13 in total

1.  A gap approach to exploring quality of life in mental health.

Authors:  J Welham; M Haire; D Mercer; T Stedman
Journal:  Qual Life Res       Date:  2001       Impact factor: 4.147

Review 2.  How antipsychotics work-from receptors to reality.

Authors:  Shitij Kapur; Ofer Agid; Romina Mizrahi; Ming Li
Journal:  NeuroRx       Date:  2006-01

3.  Quality of life and self-esteem in working and nonworking persons with mental illness.

Authors:  C J Van Dongen
Journal:  Community Ment Health J       Date:  1996-12

Review 4.  Quality-of-life instruments for severe chronic mental illness. Implications for pharmacotherapy.

Authors:  M Becker
Journal:  Pharmacoeconomics       Date:  1995-03       Impact factor: 4.981

5.  A conceptual model of quality of life in schizophrenia: description and preliminary clinical validation.

Authors:  A G Awad; L N Voruganti; R J Heslegrave
Journal:  Qual Life Res       Date:  1997-01       Impact factor: 4.147

6.  A new patient focused index for measuring quality of life in persons with severe and persistent mental illness.

Authors:  M Becker; R Diamond; F Sainfort
Journal:  Qual Life Res       Date:  1993-08       Impact factor: 4.147

7.  Demographic factors associated with extreme non-compliance in schizophrenia.

Authors:  W Sellwood; N Tarrier
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1994-07       Impact factor: 4.328

8.  The association of consumer expectations, experiences and satisfaction with newly prescribed medications.

Authors:  Ritesh N Kumar; Duane M Kirking; Steven L Hass; Amiram D Vinokur; Stephanie D Taylor; Mark J Atkinson; Patrick L McKercher
Journal:  Qual Life Res       Date:  2007-05-26       Impact factor: 4.147

9.  A comprehensive treatment program for schizophrenia and chronic mental illness.

Authors:  A S Bellack; K T Mueser
Journal:  Community Ment Health J       Date:  1986

Review 10.  Neuroleptic dysphoria: towards a new synthesis.

Authors:  L Voruganti; A G Awad
Journal:  Psychopharmacology (Berl)       Date:  2003-11-27       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.